These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 26589194)

  • 1. Multiple sclerosis and fatigue: A review on the contribution of inflammation and immune-mediated neurodegeneration.
    Patejdl R; Penner IK; Noack TK; Zettl UK
    Autoimmun Rev; 2016 Mar; 15(3):210-20. PubMed ID: 26589194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression and immunity: inflammation and depressive symptoms in multiple sclerosis.
    Gold SM; Irwin MR
    Neurol Clin; 2006 Aug; 24(3):507-19. PubMed ID: 16877121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spasticity in multiple sclerosis: Contribution of inflammation, autoimmune mediated neuronal damage and therapeutic interventions.
    Patejdl R; Zettl UK
    Autoimmun Rev; 2017 Sep; 16(9):925-936. PubMed ID: 28698092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms linking neuroinflammation and neurodegeneration in MS.
    Ellwardt E; Zipp F
    Exp Neurol; 2014 Dec; 262 Pt A():8-17. PubMed ID: 24530639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic gene expression changes in astrocytes in Multiple Sclerosis cerebral cortex are indicative of immune-mediated signaling.
    Zeis T; Allaman I; Gentner M; Schroder K; Tschopp J; Magistretti PJ; Schaeren-Wiemers N
    Brain Behav Immun; 2015 Aug; 48():313-25. PubMed ID: 25937052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Peripheral inflammation on the progression of multiple sclerosis: evidence from the clinic and experimental animal models.
    Murta V; Ferrari CC
    Mol Cell Neurosci; 2013 Mar; 53():6-13. PubMed ID: 22771835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipids at the Cross-road of Autoimmunity in Multiple Sclerosis.
    Reale M; Sanchez-Ramon S
    Curr Med Chem; 2017; 24(2):176-192. PubMed ID: 27881065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of autoimmune CNS inflammation by astrocytes.
    Rothhammer V; Quintana FJ
    Semin Immunopathol; 2015 Nov; 37(6):625-38. PubMed ID: 26223505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depression and fatigue in multiple sclerosis: Relation to exposure to violence and cerebrospinal fluid immunomarkers.
    Brenner P; Granqvist M; Königsson J; Al Nimer F; Piehl F; Jokinen J
    Psychoneuroendocrinology; 2018 Mar; 89():53-58. PubMed ID: 29324301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.
    Vercellino M; Masera S; Lorenzatti M; Condello C; Merola A; Mattioda A; Tribolo A; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
    J Neuropathol Exp Neurol; 2009 May; 68(5):489-502. PubMed ID: 19525897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging role of IL-16 in cytokine-mediated regulation of multiple sclerosis.
    Skundric DS; Cruikshank WW; Montgomery PC; Lisak RP; Tse HY
    Cytokine; 2015 Oct; 75(2):234-48. PubMed ID: 25703787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulating inflammation and neuroprotection in multiple sclerosis.
    Yong H; Chartier G; Quandt J
    J Neurosci Res; 2018 Jun; 96(6):927-950. PubMed ID: 28580582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives on cytokine-directed therapies in multiple sclerosis.
    Schreiner B; Becher B
    Swiss Med Wkly; 2015; 145():w14199. PubMed ID: 26495801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholinergic System and Neuroinflammation: Implication in Multiple Sclerosis.
    Di Bari M; Di Pinto G; Reale M; Mengod G; Tata AM
    Cent Nerv Syst Agents Med Chem; 2017; 17(2):109-115. PubMed ID: 27550615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the topography of brain damage on depression and fatigue in patients with multiple sclerosis.
    Gobbi C; Rocca MA; Riccitelli G; Pagani E; Messina R; Preziosa P; Colombo B; Rodegher M; Falini A; Comi G; Filippi M
    Mult Scler; 2014 Feb; 20(2):192-201. PubMed ID: 23812284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatigue in multiple sclerosis: mechanisms and management.
    Vucic S; Burke D; Kiernan MC
    Clin Neurophysiol; 2010 Jun; 121(6):809-17. PubMed ID: 20100665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional but not global brain damage contributes to fatigue in multiple sclerosis.
    Rocca MA; Parisi L; Pagani E; Copetti M; Rodegher M; Colombo B; Comi G; Falini A; Filippi M
    Radiology; 2014 Nov; 273(2):511-20. PubMed ID: 24927473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Origin of fatigue in multiple sclerosis: review of the literature.
    Kos D; Kerckhofs E; Nagels G; D'hooghe MB; Ilsbroukx S
    Neurorehabil Neural Repair; 2008; 22(1):91-100. PubMed ID: 17409388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleep disorders and fatigue in multiple sclerosis: evidence for association and interaction.
    Kaminska M; Kimoff RJ; Schwartzman K; Trojan DA
    J Neurol Sci; 2011 Mar; 302(1-2):7-13. PubMed ID: 21241993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.